Healwell Al

What Healwell Al does

Healwell AI is a publicly traded healthcare technology company (TSX: AIDX; OTCQX: HWAIF) headquartered in Toronto, Canada, that develops AI and data science solutions for the early identification and detection of diseases. The company was rebranded from MCI Onehealth Technologies in October 2023 following a strategic transaction with WELL Health Technologies and has since completed multiple acquisitions to assemble a vertically integrated AI healthcare platform. Its core technology is the DARWEN AI engine, which unifies the Khure Health precision medicine platform (rare disease screening), Pentavere Research Group's patient identification AI, and Abstractive Health's generative AI documentation into SMART modules (Summary, Search, Identify) that assist physicians with clinical decision support. The platform is validated through 47 peer-reviewed publications and partnerships with Princess Margaret Cancer Centre and Sunnybrook Health Sciences Centre.

The company's business model is built on recurring SaaS subscriptions, per-use AI clinical co-pilot licensing, multi-year HIE infrastructure contracts, and fee-for-service real-world evidence generation for pharmaceutical and life sciences clients. Acquired subsidiaries including Orion Health (global HIE and Amadeus Digital Care Record), Intrahealth (EMR/EHR), VeroSource Solutions (interoperability), and BioPharma Services (CRO for Phase 1/2a trials) provide multiple revenue streams and global distribution across Canada, the United States, the Middle East, Australia, and New Zealand. The exclusive strategic partnership with WELL Health Technologies provides access to 40,000+ healthcare providers and 5M+ yearly patient visits through Canada's largest EMR app ecosystem, with WELL's CEO Hamed Shahbazi serving as Chairman of HEALWELL's board.

HEALWELL serves three primary customer segments: healthcare providers and health systems (hospitals, clinics, physicians seeking AI decision support), pharmaceutical and life sciences companies (including 6 of the top 10 pharma companies for patient identification and RWE generation), and government and public health authorities (for HIE infrastructure and population health). In late 2025, the company divested non-core clinical assets to become a pure-play global SaaS, services, and AI company, achieving its first positive Adjusted EBITDA of $2.3 million in FY2025 on revenue of approximately CAD $103.8 million. Recent strategic moves include the Orion Health acquisition (April 2025), a $55M bought-deal financing, the launch of WELLTRUST and Amadeus AI (February 2026), and entry into the Middle East and US HIE markets.

Name

Healwell Al

Legal name

HEALWELL AI Inc.

Website

https://healwell.ai

Company type

Public

Founded year

2019

Operating status

Operating

Headcount range

101–250 employees

Short description

Publicly traded healthcare AI company (TSX: AIDX) providing AI-powered clinical decision support, real-world evidence generation, and health information exchange software to healthcare providers, pharmaceutical companies, and government health systems across North America, the Middle East, Oceania, and Europe.

Ownership category

akta.pro rank

Product category

Healthcare AI Software and Clinical Decision Support

NAICS

Software Publishers (5132)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO)

akta.pro secondary industries

Acute Care & Hospital EHRs (HLACAAAA), EHR Extensions, APIs, App Marketplaces & SMART-on-FHIR Apps (HLACAAAN), Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways) (HLACAFAO), SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)

Keywords

• Healthcare AI software
• Clinical decision support
• Health data interoperability
• Electronic medical records
• Real-world evidence

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. SaaS and Software Licensing: High-margin recurring revenue from SaaS subscriptions for EMR, practice management, interoperability, and HIE platforms. Includes Orion Health, Intrahealth, and VeroSource software products.
2. AI-Powered Clinical Decision Support: Subscription and per-use revenue from AI clinical co-pilot tools deployed to healthcare providers through WELL Health ecosystem and direct enterprise agreements.
3. Clinical Research Services (CRO): Revenue from BioPharma Services' contract research organization operations including Phase 1 and Phase 2a clinical trials, bioanalysis, and regulatory affairs services.
4. Real-World Evidence and Data Analytics: Fee-for-service and contract revenue from pharmaceutical partners for AI-powered patient identification, data analysis, and real-world evidence generation using the DARWEN platform.
5. Interoperability and HIE Services: Multi-year software contracts for health information exchange infrastructure supporting secure data aggregation and exchange across hospital systems, clinics, and public health agencies.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Core offering

Healwell AI develops and sells AI-powered healthcare technology focused on early disease detection and preventative care. Its core offering is the DARWEN AI platform, a unified engine integrating Khure Health and Pentavere capabilities for clinical decision support, rare/chronic disease screening, and real-world evidence generation. The company also provides EMR/EHR software (Intrahealth), health data interoperability/HIE platforms (Orion Health Amadeus, VeroSource), and contract research organization services (BioPharma Services), sold primarily to healthcare providers, pharmaceutical companies, and government health authorities.

Product overview

HEALWELL AI is a healthcare technology company offering a platform-plus-modules architecture centered around its proprietary DARWEN AI engine. The core offering includes AI-powered clinical decision support tools (CDS) for disease detection, risk stratification, and patient care optimization. Key modules include SMART Search, SMART Summary, and SMART Identify, which are integrated into the Orion Health Amadeus platform. The portfolio spans acquired brands including Khure Health (rare disease screening), Pentavere Research Group (patient identification AI), Intrahealth (EMR/EHR solutions), VeroSource Solutions (healthcare data interoperability), Orion Health (healthcare data integration), and BioPharma Services (clinical research). Strategic investments include Abstractive Health (clinical documentation AI) and Mutuo Health (ambient scribe). The company also offers WELLTRUST, a consent-first clinical research recruitment platform developed in partnership with WELL Health Technologies.

Differentiator

Problem solved

Functional benefit

Products and services

• DARWEN AI Platform Proprietary AI platform powering disease detection and clinical decision support, integrating Khure and Pentavere AI capabilities into a unified engine for early identification of rare and chronic diseases. Validated through 47 peer-reviewed publications.
• Khure Health AI precision medicine platform that harnesses clinical data to enable physicians to rapidly screen and identify patients with rare diseases and facilitate personalized treatment.
• Pentavere Research Group Healthcare AI company with a best-in-class AI engine to identify patients eligible for approved medications or interventions, improving outcomes and driving therapy growth.
• Intrahealth EMR/EHR management platform for small and medium enterprise healthcare organizations across Canada, Australia, and New Zealand, supporting clinical documentation, scheduling, and billing.
• VeroSource Solutions Cloud-based healthcare data interoperability platform providing end-to-end, customizable solutions for population health management and health information exchange (including the New Brunswick MyHealthNB Patient Summary platform serving over 600,000 residents).
• Orion Health Global healthcare technology company providing the Unified Healthcare Platform (Virtuoso Digital Front Door and Amadeus Digital Care Record) for healthcare data integration and interoperability, with deployments across the US, Canada, Middle East, Australia, and New Zealand.
• BioPharma Services Contract research organization (CRO) specializing in Phase 1 and Phase 2a clinical trials with GLP-certified laboratory, regulatory affairs, biostatistics, and safety data analysis capabilities.
• Mutuo Health Solutions (AutoScribe) AI-powered ambient scribe solution that transcribes clinician-patient interactions into high-quality electronic medical records in real time using NLP and machine learning.
• WELLTRUST Platform Consent-first data governance and patient-identification platform enabling secure, privacy-preserving patient data mobilization for clinical research recruitment at WELL-operated clinics.
• Amadeus AI Next-generation AI-enabled digital care record integrated with Orion Health's Amadeus platform, providing AI-powered clinical intelligence across healthcare systems.
• Clinical Decision Support (CDS) Tool Analyzes electronic medical record data to support guideline-based insights, disease detection, risk stratification, and patient care optimization for healthcare providers.
• AI-Powered Co-pilot for Cardiologists AI tool deployed across diagnostic centres to assist cardiologists in identifying patients at high risk of cardiovascular disease.
• SMART Identify AI module integrated into Orion Amadeus platform for patient identification and matching across healthcare systems, identifying high-risk patients and matching them with clinical trials and research opportunities.

Quantifiable outcome

• Q1 2026 revenue of CAD $33.2 million, representing 316% year-over-year growth
• +4 more outcomes

Named customers7 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature8 records

Partnerships

Five partnerships are on record, tiered core and minor.

• WELL Health TechnologiescoreStrategic or Co-development PartnerExclusive strategic partnership providing HEALWELL access to Canada's largest EMR app ecosystem and 40K+ healthcare providers. WELL is HEALWELL's lead investor and key distribution channel for AI clinical co-pilot technologies.
• Abstractive HealthcoreStrategic or Co-development PartnerUS$250,000 strategic investment with exclusive distribution rights to Canadian outpatient healthcare market. Abstractive Health's generative AI documentation technology extends HEALWELL's AI co-pilot suite.
• xAIminorStrategic or Co-development PartnerUSD $2,000,000 strategic investment in xAI through T1P investment vehicle, gaining access to closed xAI Developer Program for healthcare-focused LLM development.
• doctorlyminorStrategic or Co-development PartnerStrategic investment and alliance to bring HEALWELL's clinical decision support to European market, targeting Germany's healthcare provider base.
• Lean Business ServicesminorStrategic or Co-development PartnerMemorandum of Understanding signed between Orion Health and Lean Business Services to advance AI-powered healthcare in Saudi Arabia and across the Middle East.

Scale indicators13 records

Recent moves9 records

Expansion highlights8 records

Direct peers

• WELL Health Technologies: Parent and lead investor of HEALWELL; operates Canada's largest EMR ecosystem and the apps.health marketplace that distributes HEALWELL's AI co-pilot tools to 40K+ providers. Closely aligned business model combining clinic networks, EMR software, and digital health SaaS.
• Tempus AI: AI-enabled precision medicine company that uses clinical and molecular data to support disease detection, patient identification, and pharma partnerships. Closest US-comparable business model to HEALWELL's DARWEN-powered disease detection and RWE offering.
• Suki AI: Private AI-powered clinical documentation and ambient scribe company sold to health systems and physician groups. Directly comparable to HEALWELL's Mutuo/AutoScribe and Abstractive Health partnerships for AI-generated clinical summaries.
• Abridge: Private AI clinical documentation company using generative AI to convert patient-clinician conversations into structured EMR notes. Comparable to HEALWELL's SMART Summary and AutoScribe offerings for reducing clinician documentation burden.
• 1upHealth: Private health data interoperability platform built on FHIR APIs for payers, providers, and app developers. Directly comparable to HEALWELL's VeroSource and Orion Health HIE/interoperability offerings and SMART-on-FHIR integration strategy.

Broad incumbents

• Veeva Systems: Public healthcare and life sciences SaaS leader serving pharma and biotech with cloud software, including real-world evidence and clinical data platforms. Comparable as a high-margin, recurring-revenue healthcare SaaS business with similar enterprise pharma GTM.
• Certara: Public biosimulation and real-world evidence software company serving pharma with regulatory-grade data analytics and clinical development tools. Comparable as a pharma-facing AI/analytics platform generating regulatory-grade evidence.
• Doximity: Public physician network and digital tools platform with subscription SaaS revenue from healthcare providers. Comparable SaaS business model targeting physicians and health systems with workflow and clinical decision support tools.
• Veradigm (formerly Allscripts): Public healthcare IT vendor offering EHR/EMR, practice management, and data interoperability solutions to hospitals and ambulatory providers. Comparable via HEALWELL's Intrahealth and Orion Health EHR/HIE product lines serving similar hospital and clinic customers.

Emerging players

• Recursion Pharmaceuticals: Public clinical-stage biotech using AI/ML platforms to accelerate drug discovery and identify patient populations. Comparable in applying AI to biomedical data and building pharma partnerships, though more upstream in drug discovery versus HEALWELL's detection focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Healwell_AI
• YouTubeyoutube.com/@HEALWELLAI
• Facebookfacebook.com/HealWell-AI
• LinkedInlinkedin.com/company/healwellai
• Instagraminstagram.com/healwell.ai

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries7 records

Funding overview

Funding rounds9 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A8 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Healwell Al